Literature DB >> 9701240

State of the art: atherosclerosis in a limited edition.

D J Rader, G A FitzGerald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9701240     DOI： 10.1038/nm0898-899

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Antidyslipidemic effect and antioxidant activity of anthraquinone derivatives from Rheum emodi rhizomes in dyslipidemic rats.

Authors:  Sunil K Mishra; Shashi Tiwari; Atul Shrivastava; Shishir Srivastava; Goutam K Boudh; Shivendra K Chourasia; Upma Chaturvedi; Snober S Mir; Anil K Saxena; Gitika Bhatia; Vijai Lakshmi
Journal:  J Nat Med       Date:  2013-12-17       Impact factor: 2.343

2.  Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia.

Authors:  Jenny A Greig; Maria P Limberis; Peter Bell; Shu-Jen Chen; Roberto Calcedo; Daniel J Rader; James M Wilson
Journal:  Hum Gene Ther Clin Dev       Date:  2017-03       Impact factor: 5.032

3.  Pharmacological evaluation of the efficacy of Dysoxylum binectariferum stem bark and its active constituent rohitukine in regulation of dyslipidemia in rats.

Authors:  Sunil K Mishra; Shashi Tiwari; Shishir Shrivastava; Ravi Sonkar; Vaibhav Mishra; Sunil K Nigam; Anil K Saxena; Gitika Bhatia; Snober S Mir
Journal:  J Nat Med       Date:  2014-03-28       Impact factor: 2.343

4.  Biodistribution of AAV8 vectors expressing human low-density lipoprotein receptor in a mouse model of homozygous familial hypercholesterolemia.

Authors:  Shu-Jen Chen; Julio Sanmiguel; Martin Lock; Deirdre McMenamin; Christine Draper; Maria P Limberis; Sadik H Kassim; Suryanarayan Somanathan; Peter Bell; Julie C Johnston; Daniel J Rader; James M Wilson
Journal:  Hum Gene Ther Clin Dev       Date:  2013-11-09       Impact factor: 5.032

Review 5.  Gene therapy for dyslipidemia: clinical prospects.

Authors:  D J Rader; U J Tietge
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.113

6.  Contrast Ultrasound Imaging of the Aorta Does Not Affect Progression of Atherosclerosis or Cardiovascular Biomarkers in ApoE-/- Mice.

Authors:  Brendon W Smith; Douglas G Simpson; Sandhya Sarwate; Rita J Miller; John W Erdman; William D O'Brien
Journal:  J Ultrasound Med       Date:  2015-06       Impact factor: 2.153

7.  Time course of intermittent hypoxia-induced impairments in resistance artery structure and function.

Authors:  Nathan R Philippi; Cynthia E Bird; Noah J Marcus; E Burt Olson; Naomi C Chesler; Barbara J Morgan
Journal:  Respir Physiol Neurobiol       Date:  2009-12-05       Impact factor: 1.931

8.  Adeno-associated virus serotype 8 gene therapy leads to significant lowering of plasma cholesterol levels in humanized mouse models of homozygous and heterozygous familial hypercholesterolemia.

Authors:  Sadik H Kassim; Hui Li; Peter Bell; Suryanarayan Somanathan; William Lagor; Frank Jacobs; Jeffrey Billheimer; James M Wilson; Daniel J Rader
Journal:  Hum Gene Ther       Date:  2012-11-14       Impact factor: 5.695

9.  SVEP1 is a human coronary artery disease locus that promotes atherosclerosis.

Authors:  In-Hyuk Jung; Jared S Elenbaas; Arturo Alisio; Katherine Santana; Erica P Young; Chul Joo Kang; Puja Kachroo; Kory J Lavine; Babak Razani; Robert P Mecham; Nathan O Stitziel
Journal:  Sci Transl Med       Date:  2021-03-24       Impact factor: 17.956

10.  Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain.

Authors:  Ildikó Lantos; Valéria Endrész; Dezső Péter Virok; Andrea Szabó; Xinjie Lu; Tímea Mosolygó; Katalin Burián
Journal:  Biomed Res Int       Date:  2018-03-25       Impact factor: 3.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.